Author:
Amodeo Dionisio A.,Peterson Sophie,Pahua Alma,Posadas Rebekah,Hernandez Armando,Hefner Emily,Qi David,Vega Jesus
Funder
National Institute of General Medical Sciences
Reference69 articles.
1. Antagonism of the 5-HT6 receptor–Preclinical rationale for the treatment of Alzheimer's disease;de Jong;Neuropharmacology,2017
2. AVN-322 is a safe orally bio-available potent and highly selective antagonist of 5-HT6R with demonstrated ability to improve impaired memory in animal models;Ivachtchenk;Curr. Alzheimer Res.,2017
3. 5-HT 6 receptors: a novel target for cognitive enhancement;Mitchell;Pharmacol. Ther.,2005
4. 5‐HT6 antagonists as potential treatment for cognitive dysfunction;Liu;Drug Dev. Res.,2009
5. 5-HT6 receptor memory and amnesia: behavioral pharmacology—learning and memory processes;Meneses;Int. Rev. Neurobiol.,2011
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献